| Literature DB >> 28270166 |
Ayman El-Menyar1,2,3, Mohammad Asim4, Insolvisagan N Mudali5, Ahammed Mekkodathil4, Rifat Latifi6, Hassan Al-Thani7.
Abstract
BACKGROUND: Necrotizing fasciitis (NF) is a devastating soft tissue infection associated with potentially poor outcomes. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score has been introduced as a diagnostic tool for NF. We aimed to evaluate the prognostic value of LRINEC scoring in NF patients.Entities:
Keywords: LRINEC score; Necrotizing fasciitis; Outcomes; Prognosis; SOFA score; Sepsis
Mesh:
Year: 2017 PMID: 28270166 PMCID: PMC5341454 DOI: 10.1186/s13049-017-0359-z
Source DB: PubMed Journal: Scand J Trauma Resusc Emerg Med ISSN: 1757-7241 Impact factor: 2.953
Study definitions
| Laboratory Risk Indicator For Necrotizing Fasciitis | |
|---|---|
| Variable (units) | Score points |
| C-Reactive Protein (CRP) (mg/L) | |
| <150 | 0 |
| White blood cell count (per mm3) | |
| <15 | 0 |
| Hemoglobin (g/dl) | |
| >13.5 | 0 |
| Serum Sodium (mmol/L) | |
| ≥135 | 0 |
| Serum Creatinine (mg/dl) | |
| ≤1.6 | 0 |
| Serum Glucose (mg/dl) | |
| ≤180 | 0 |
| Types of NF based on microorganisms | |
| Type I | NF comprised of synergistic polymicrobial infection |
| Type II | NF is caused by monomicrobial gram positive organisms |
| Type III | NF involves gram negative monobacteria usually marine-related organisms |
| Type IV | NF is caused by fungal infection |
Fig. 1Frequency of LRINEC scoring [n=294, mean±SD (6.3±2.9)]
Demographics, comorbidities, region of infection and outcomes in patients with NF
| LRINEC <6 (45%) | LRINEC ≥6 (55%) | P | |
|---|---|---|---|
| Age, years (mean ± SD) | 48 ± 15 | 53 ± 16 | 0.009 |
| Males (%) | 74 | 73 | 0.82 |
| Diabetes Mellitus (%) | 41.5 | 61.4 | 0.001 |
| Kidney disease % | 10 | 20 | 0.02 |
| Hypertension% | 28 (21.5) | 74 (46.8) | 0.001 |
| Site of infection % | |||
| Lower limbs | 49 | 55 | 0.32 |
| Perineum & genitalia | 35.3 | 34.8 | 0.92 |
| Abdominal and groin | 12.0 | 8.7 | 0.34 |
| Chest & breast | 3.0 | 2.5 | 0.78 |
| Face & neck | 6.0 | 7.5 | 0.62 |
| Number of debridement | 2.14 ± 1.5 | 2.09 ± 1.3 | 0.81 |
| Number of antibiotics useda (%) | |||
| ≤2 | 81 (78.6) | 83 (56.8) | 0.001 for all |
| >2 | 22 (21.4) | 63 (43.2) | |
| Hospital LOS; days | 11 (2–115) | 22 (2–129) | 0.001 |
| intensive care LOS; days | 5 (2–34) | 7 (1–75) | 0.01 |
| Septic shock (%) | 15 | 37 | 0.001 |
| Mortality (%) | 15 | 28.8 | 0.005 |
aFrequently used antibiotics are Tazocin, Clindamycin, Meropenem and Agumentin
Laboratory results
| LRINEC <6 | LRINEC ≥6 |
| |
|---|---|---|---|
| Streptococcus (%) | 51(40.8) | 45 (33.1) | 0.19 |
| Staphylococcus (%) | 47(37.6) | 49 (35.8) | 0.76 |
| Bacteroides (%) | 30 (24.0) | 26 (18.9) | 0.32 |
| Escherichia coli (%) | 15 (12) | 16 (11.6) | 0.92 |
| Pseudomonas (%) | 3 (2.4) | 16 (11.7) | 0.004 |
| Proteus mirabilis (%) | 0 (0) | 5(3.6) | 0.06 |
| Gram positive (%) | 94 (82.5) | 99 (76.2) | 0.09 |
| Gram negative (%) | 48 (42.1) | 71 (54.6) | 0.08 |
| Causative bacteria (%) | |||
| Type I (polybacterial) (%) | 36 (31.6) | 38 (29.2) | 0.06 for all |
| Type II (Monobacterial) (%) | 70 (61.4) | 70 (53.8) | |
| Type III (Murine bacteria) (%) | 0 (0) | 0 (0) | |
| Type IV (Fungal) (%) | 8 (7.0) | 22 (16.9) | |
| C-Reactive protein level, mean±SD | 119 ± 82 | 249 ± 111 | 0.001 |
| Initial Procalcitonin level, median (range) | 0.85(0.09-182) | 8.1(0.07-303) | 0.127 |
| SOFA score | |||
| Mean | 8.7 ± 2.4 | 11.6 ± 3.3 | 0.001 |
| Median | 8 (2-19) | 11 (4-21) | |
| LRINEC score | |||
| Mean | 3.7 ± 1.1 | 8.4 ± 2.1 | 0.001 |
| Median | 4 (1-5) | 8 (6-13) | |
Predictors of hospital outcomes in NF
| Risk of Mortality | |||
|---|---|---|---|
| Odds ratio | 95% CI |
| |
| LRINEC score | 1.20 | 1.09–1.29 | 0.01 |
| Age | 1.07 | 1.04–1.09 | 0.001 |
| Risk of Septic Shock | |||
| LRINEC score | 1.30 | 1.15–1.41 | 0.001 |
| Age | 1.02 | 1.001–1.041 | 0.042 |
Fig. 2A Boxplot chart of the time to death in NF patients based on the LRINEC scoring
Fig. 3ROC curve for LRINEC scoring points in the prediction of septic shock: Area under the curve 0.70; 95% confidence interval 0.63-0.78, p<0.001. LRINEC scoring cut-off value 5 with 82% sensitivity and 72% specificity
Fig. 4ROC curve for LRINEC scoring points in the prediction of mortality: Area under the curve 0.64; 95% confidence interval 0.57-0.71, p<0.001. LRINEC scoring cut- off value 8.5 with 81% sensitivity and 36% specificity
Outcomes based on LRINEC status
| Not available | LRINEC <6(group1) | LRINEC ≥6(group2) | P | |
|---|---|---|---|---|
| Patients number | 37 | 133 | 161 | |
| SOFA score; mean ± SD | 7.6 ± 1.1 | 8.7 ± 2.3 | 11.5 ± 3.3 | 0.001 |
| Septic shock % | 25.8 | 15.2 | 37 | 0.001 |
| Mortality% | 18.9 | 15 | 28.6 | 0.05 |
Summary of studies on the prognostic role of LRINEC in NF patients
| Study | Country | Design | Results |
|---|---|---|---|
| Su et al. [ | Taiwan | Retrospective study (2002–2005) | Patients with a LRINEC score of ≥6 have a higher rate of both mortality and amputation. |
| Corbin et al. [ | France | Prospective study | The rate of complications was higher for patients with a LRINEC score > 6 than for patients with a score < 6. |
| Swain et al. [ | UK | Retrospective study | Overall mortality was 3 out of 15 patients. The median LRINEC score in all deaths was 9.0 (range: 6–12). |
| Bozkurt et al. [ | Turkey | Retrospective study | Patients with higher LRINEC scores were more likely to require mechanical ventilation and longer hospitalization times and were more likely to die |
| COLAK et al. [ | Turkey | Retrospective study (2008–2013 | The mean number of debridements and LRINEC score were higher in the non-surviving group ( |
| El-Menyar et al. 2017 | Qatar | Retrospective study | LRINEC ≥6 had greater SOFA score (11.5 ± 3 vs 8 ± 2) septic shock (37% vs 15%), prolonged hospital length of stay and deaths ( |
Fig. 5Patient with NF of left chest wall extending from left axilla to left groin and scrotum. a) Post-surgical debridement of the chest and abdominal wall; b) Wound VAC placement on the same patient; c & d: Two consecutive images of reconstruction of the same wound with skin graft